Because of their poor metabolic stability and limited blood-brain barrier permeability, endomorphins have a low analgesic efficacy when administered systemically. Therefore, it is of great importance to design analogues with improved peptidase resistance and better delivery to the central nervous system. Recently, novel endomorphin-2 analogues have been synthesized, which proved to bind with high affinity and selectivity to the μ-opioid receptors and showed proteolytic resistance. In this study, we have analysed the transport characteristics of endomorphin-2 and three of its analogues [Dmt-Pro-Phe-Phe-NH 2, Tyr-(1S,2R)Acpc-Phe-Phe-NH 2 and Tyr-(1S,2R)Achc-Phe-Phe-NH 2] using an in vitro blood-brain barrier model. The lipophilicity of the analogues, as assessed by their octanol/water partition coefficients, was higher than that of endomorphin-2. The flux of all four peptides from the apical (blood) side to the basolateral (brain) side was not saturable in the 10nm-1mm concentration range, suggesting that a passive mechanism plays a major role in their transport. The permeability coefficient of the analogues was significantly higher than that of endomorphin-2, suggesting increased blood-brain barrier penetration properties. We conclude that because of their good peptidase resistance and improved transport through brain endothelial cells, these endomorphin-2 analogues will have better analgesic properties in vivo. © 2011 John Wiley & Sons A/S.
CITATION STYLE
Mallareddy, J. R., Tóth, G., Fazakas, C., Molnár, J., Nagyoszi, P., Lipkowski, A. W., … Wilhelm, I. (2012). Transport Characteristics of Endomorphin-2 Analogues in Brain Capillary Endothelial Cells. Chemical Biology and Drug Design, 79(4), 507–513. https://doi.org/10.1111/j.1747-0285.2011.01306.x
Mendeley helps you to discover research relevant for your work.